Published in Am J Kidney Dis on December 12, 2008
Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol (2011) 1.77
Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71
Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65
A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol (2010) 1.52
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int (2010) 1.47
Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis (2010) 1.44
Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol (2015) 1.40
Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.35
Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32
Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis (2011) 1.31
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig (2012) 1.30
Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2010) 1.24
Neuropsychiatric complications of chronic kidney disease. Nat Rev Nephrol (2010) 1.08
Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant (2012) 1.06
The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis (2012) 1.04
Reference data for the Ruff Figural Fluency Test stratified by age and educational level. PLoS One (2011) 1.02
Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract (2010) 1.01
Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci (2013) 1.01
Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology (2010) 1.00
Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND. Diabetes Care (2014) 0.98
Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol (2010) 0.96
Albuminuria and cognitive decline in people with diabetes and normal renal function. Clin J Am Soc Nephrol (2013) 0.95
Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant (2011) 0.93
Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig (2016) 0.87
Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study. Alzheimer Dis Assoc Disord (2015) 0.87
Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation. J Diabetes Investig (2014) 0.86
Kidney function and cognitive health in older adults: the Cardiovascular Health Study. Am J Epidemiol (2014) 0.86
Cerebral small vessel disease and renal function: systematic review and meta-analysis. Cerebrovasc Dis (2014) 0.85
Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes. Dement Geriatr Cogn Dis Extra (2013) 0.85
Connecting cerebral white matter lesions and hypertensive target organ damage. J Aging Res (2011) 0.84
Cognitive impairment in dialysis patients: focus on the blood vessels? Am J Kidney Dis (2013) 0.84
Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc (2012) 0.84
Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus. Metabolism (2014) 0.82
Cognitive and physical function in chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.81
Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND. Nephrol Dial Transplant (2015) 0.79
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology (2016) 0.78
Should an elderly patient with stage V CKD and dementia be started on dialysis? Clin J Am Soc Nephrol (2013) 0.78
Retinal microvascular signs and disability in the Cardiovascular Health Study. Arch Ophthalmol (2011) 0.78
Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes. Diabetes Care (2015) 0.78
The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms. Transl Stroke Res (2016) 0.77
Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine. PLoS One (2013) 0.77
Reduced white matter integrity and cognitive deficits in maintenance hemodialysis ESRD patients: a diffusion-tensor study. Eur Radiol (2014) 0.77
Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study. Brain Behav (2015) 0.77
Cognitive impairment and depression in a population of patients with chronic kidney disease in Colombia: a prevalence study. Can J Kidney Health Dis (2016) 0.77
Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages. Semin Nephrol (2015) 0.77
Arterial stiffness and impaired renal function in patients with Alzheimer's disease. Neurol Sci (2015) 0.76
Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review. Alzheimer Dis Assoc Disord (2016) 0.75
Polyclonal light chains in cerebrovascular disease. Neuropsychiatr Dis Treat (2010) 0.75
A disease modification effect of APOE E4 on the association between urinary albumin excretion and cognition in Korean adults. Dis Markers (2014) 0.75
Consequences of CKD on Functioning. Semin Nephrol (2016) 0.75
Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study. J Gerontol A Biol Sci Med Sci (2015) 0.75
Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int (2017) 0.75
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr (2014) 0.75
Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT). J Ren Nutr (2011) 0.75
Urinary albumin to creatinine ratio as potential biomarker for cerebral microvascular disease. Curr Neurovasc Res (2014) 0.75
Kidney-brain crosstalk in the acute and chronic setting. Nat Rev Nephrol (2015) 0.75
Cognitive impairment in chronic kidney disease: keep vascular disease in mind. Kidney Int (2014) 0.75
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis (2017) 0.75
Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus. Am J Kidney Dis (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med (2003) 3.78
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Subcortical ischaemic vascular dementia. Lancet Neurol (2002) 3.32
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82
Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol (2003) 2.70
Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet (2007) 2.51
Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis (2003) 2.44
Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension (2005) 2.18
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis (2006) 2.16
Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology (1997) 2.13
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis (2008) 1.96
High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis (2007) 1.88
Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88
Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med (2005) 1.77
Estimating stature from knee height for persons 60 to 90 years of age. J Am Geriatr Soc (1985) 1.77
The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry (2006) 1.50
The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci (2004) 1.46
Subcortical cognitive impairment in dialysis patients. Hemodial Int (2007) 1.38
Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci (1995) 1.36
Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc (2003) 1.32
Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med (2004) 1.11
Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002. J Intern Med (2007) 0.97
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA (2005) 9.61
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci (2004) 4.81
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30
Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med (2002) 4.24
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72
Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis (2007) 3.53
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant (2008) 3.41
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05
Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet (2003) 3.00
Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol (2009) 3.00
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83
Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82
Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med (2002) 2.81
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med (2012) 2.69
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med (2010) 2.67
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62
Clinical practice guidelines in nephrology--for worse or for better. Nephrol Dial Transplant (2006) 2.58
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol (2002) 2.58
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis (2010) 2.41
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int (2004) 2.38
Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens (2006) 2.34
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician (2004) 2.27
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol (2002) 2.25
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ (2013) 2.24
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22